Abstract
All over the world, breast carcinoma is the most common tumour to affect women. Ocular metastatic foci in breast carcinoma leading to visual morbidity can occur both as a complication of active cancer and as an adverse effect of treatment. Metastases may cause both intra- and extraocular sequelae. Uveal tissue is the predominant site of metastatic disease due to its high vascularity, increased blood flow and architecture of blood vessels. Choroidal metastases are usually detected 3 years after diagnosis of primary breast carcinoma and are rarely the initial manifestation. Metastatic lesions appear as yellow, plateau-shaped, ill-defined masses of 3 mm thickness with subretinal fluid.
Complaints are usually painless blurred vision or may be asymptomatic. The various ophthalmic treatment options for choroidal metastases are external beam radiotherapy, plaque radiotherapy systemic chemotherapy, adjuvant hormone therapy, enucleation and observation. Ocular tumour regression is comparable in those who receive radiotherapy or systemic treatment. In those with ocular metastases, the mean survival time is about 21 months. The ophthalmologist has an important role in the detection of metastatic disease and during follow-up. Prompt management with local and systemic therapy will improve visual prognosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2009;59:225–49.
Demirci H, Shields CL, Chao A, Shields JA. Uveal metastasis from breast cancer in 264 patients. Am J Ophthalmol. 2003;136:264–71.
Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104:1265–76.
Mejia-Novelo A, Varado-Miranda A, Morales-Vazquez F, et al. Ocular metastases from breast carcinoma. Med Oncol. 2004;21:217–21.
Fenton S, Kemp EG, Harnett AN. Screening for ophthalmic involvement in asymptomatic patients with metastatic breast carcinoma. Eye (Lond). 2004;18(1):38–40.
d’Abbadie I, Arriagada R, Spielmann M, Le MG. Choroid metastases: clinical features and treatments in 123 patients. Cancer. 2003;98:1232–8.
Mathis T, Jardel P, Loria O, Delaunay B, Nguyen AM, Lanza F, Mosci C, Coujolle JP, Kodjikian L, Thariat J. New concepts in the diagnosis and management of choroidal metastases. Prog Retin Eye Res. 2019;68:144–17.
Arepalli S, Kaliki S, Shields CL. Choroidal metastases: origin, features and therapy. Indian J Ophthalmol. 2015;63(2):122–7.
Merrill CF, Kaufman DI, Dimitrov NV. Breast cancer metastatic to the eye is a common entity. Cancer. 1991;68:623–7.
Vishnevskia-Dai V, Zur D, Yaacobi S, Moroz I, Newman H, Neudorfer M. Optical coherence tomography: an adjunctive tool for differentiating between choroidal melanoma and metastasis. J Ophthalmol. 2016;2016:9803547.
Swampillai AJ, Boothe AP, Cohen VM. Ciliary body and iris metastases with anterior chamber angle infiltration L a rare complication from invasive ductal breast cancer. J Glaucoma. 2020;29(3):e12–5.
Suhr KS, Sperber LT, Marr P, Kahn JB. Unusual case of iris metastases from breast carcinoma. JCRS Online Case Reports. 2015;3(1):8–11.
Kim CU, Pearce WA. Metastatic breast carcinoma involving the optic disc. Am J Ophthalmol Case Rep. 2020;18:100698.
Fox B, Pacheco P, De Monte F. Carcinoma of the breast metastatic to the optic nerve mimicking an optic nerve sheath meningioma: case report and review of the literature. Skull Base. 2005;15(4):281–7.
Scott BJ, Kesari S. Leptomeningeal metastases in breast cancer. Am J Cancer Res. 2013;3(2):117–26.
Madgula IM, Hemmerdinger CM, Clark P. Metastatic breast cancer presenting as sequential cranial nervepalsy: a case report. J Med Case Rep. 2014;8:430.
Massot-Punyer R, Almajano J, Camacho JM. Cerebral metastasis. Rev Neurol. 2000;31:1242–7.
Ahmad SM, Esmaeli B. Metastatic tumours of the orbit and ocular adnexa. Curr Opin Ophthalmol. 2007;18(5):405–13.
Framarino-Dei-Malatesta M, Chiarito A, Bianciardi F, Fiorelli M, Ligato A, Pecorella I. Metastases to extraocular muscles from breast cancer: case report and up-to-date review of the literature. BMC Cancer. 2019;19(1):36.
Fonseca NL, Lucci LMD, Cha SB, Rosetti C, Rehder JRCL. Metastatic eyelid disease associated with primary breast carcinoma: case report. Arq Bras Oftalmol. 2009;72(3):390–3.
Martin J, Fung MA, Lin LK. Breast cancer metastasis masquerading as the great masquerader: sebaceous cell carcinoma. Case Rep Oncol. 2017;10(2):485–8.
Hojlo MM, Ejma M, Gorczyca WA, Szymaniec S, Witkowsk D, Fortuna W, Miedzybrodzki R, Rogozinska-Szczepka J, Bartnik W. Cancer-associated retinopathy in patients with breast carcinoma. Arch Immunol Ther Exp. 2007;55(4):261–5.
Alwitry A, Gardner I. Tamoxifenmaculopathy. Arch Ophthalmol. 2002;120:140.
Ugurlu S, Karagoz A, Ekin MA. Ocular findings in breast cancer patients using tamoxifen. Cutan Ocul Toxicol. 2015;34(1):16–20.
Zinchuk O, Watanabe M, Hayashi N, et al. A case of tamoxifenkeratopathy. Arch Ophthalmol. 2006;124:1046–8.
Manquez ME, Brown MM, Shields CL, Shields JA. Management of choroidal metastases from breast carcinomas using aromatase inhibitors. Curr Opin Ophthalmol. 2006;17(3):251–6.
Gianni L, Panzini I, Li S, Gelber RD, Collins J, Holmberg SB, Crivellari D, Castiglione-Gertsch M, Goldhirsch A, Coates AS, Ravaiolo A, International Breast Cancer Study Group (IBCSG). Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials. Cancer. 2006;106(3):505–13.
Shaik R, Tariq K, Sharma S, Tang S-C. Metastatic breast cancer presenting as orbital mass: a case report with literature review. J Glob Oncol. 2018;4:1–4.
Amer R, et al. Treatment options in the management of choroidal metastases. Ophthalmologica. 2004;218(6):372–7.
Lim JI, Petrovich Z. Radioactive plaque therapy for metastatic choroidal carcinoma. Ophthalmology. 2000;107:1927–31.
Lin CJ, Tsai YY. The effect of intravitreal bevacizumab and transpupillary thermotherapy on choroidal metastases and literature review. Indian J Ophthalmol. 2015;63(1):37–41.
Kaliki S, Shields CL, Dahmash SA, Mashayekhi A, Shields JA. Photodynamic therapy for choroidal metastasis in 8 cases. Ophthalmology. 2012;119(6):1218–22.
Chen CJ, McCoy AN, Brahmer J, Handa JT. Emerging treatments for choroidal metastases. Surv Ophthalmol. 2011;56(6):511–21.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Annamalai, R., Dev, B. (2023). Visual Morbidity and Ocular Disease in Metastatic Breast Carcinoma. In: Dev, B., Joseph, L.D. (eds) Holistic Approach to Breast Disease. Springer, Singapore. https://doi.org/10.1007/978-981-99-0035-0_34
Download citation
DOI: https://doi.org/10.1007/978-981-99-0035-0_34
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-0034-3
Online ISBN: 978-981-99-0035-0
eBook Packages: MedicineMedicine (R0)